News | May 23, 2025
Venus Remedies secures Ukrainian GMP renewal
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
